By Rhea Healy2016-06-09T10:15:00+01:00
Cryoport Inc. has signed a strategic agreement with virtual biobank, Tissue Solutions, to transport its human bio specimens to over 100 companies in the pharmaceutical and biotech industry.
Tissue Solution will use Cryport’s logistics management platform, Cryoport Express® dry vapour dewars and advanced Smart Pak IITM conditioning monitoring systems to ship isolated human cells and cryopreserved cell lines to customers across the globe.
The SmartPak system works in tandem with Cryoport’s data management platform, the CryoportalTM, to provide automated alerts on changes in transit conditions and potential temperature fluctuations.
Jerrell Shelton, CEO of California–based business Cryoport, explained, “Tissue Solutions depends on the support that only Cryoport can bring in supporting its highly successful services with Cryoport’s advanced cryogenic logistics expertise and technology, including our highly engineered and validated cryogenic cold chain shippers accompanied by crucial real-time and archived information.”
Cryoport, Inc. is expanding its geographical reach for its reproductive medicine (IVF) shipping and logistics solutions to include Cambodia and the Czech Republic.
A strategic partnership between US-based companies, Worthington Industries and Cryoport, has been established, in which Worthington will design and manufacture biostorage and logistics equipment for use in Cryoport’s life sciences cryogenic logistics solutions.
Month on month the gasworld website continues to be the primary portal for information, on a global scale, about our industry - be it through the provision of news and features, or information in the expansive company directory section. Launched in 2004, it is the only independent online news provider and information portal for the global industrial gas community and the larger end-user markets. The website also now incorporates news for gasworld US and Specialty Gas Report.
To find out more about gasworld's advertising opportunities click here.